-
dates Materials submitted by September 15, 2025 will receive full consideration. Applications received after this date will be reviewed on a rolling basis. The target start date is January 1, 2026
-
treatment targets and learn more about the genetic abnormalities that underlie cancer. IUSM is committed to being a welcoming campus community and we seek candidates whose research, teaching, and community
-
of Medicine. The candidates will work on funded projects with a focus on translational cancer immunology and drug discovery. The recruits will be joining projects in targeting the Nrf2 pathways and nuclear
-
neurodevelopment in rodent seizure models. Our primary goal is to identify molecular targets for novel treatment strategies. The laboratory employs a variety of molecular techniques, longterm continuous EEG
-
Institute (SFEI) focused on determining the role of releases in water bodies of pollutants from building materials. The main targets of the proposal are PFAS, other industrial chemicals will be of interest
-
by combining genomics, fluid biomarkers and advanced neuroimaging and 3) to identify novel targets for diagnostic applications and therapeutic intervention. Fellows will work on research problems
-
to identify novel targets for diagnostic use and therapeutic intervention. Fellows will work on research problems using rich data sets and leading-edge analytic approaches supported by multiple NIH grants (R, U